Skip to main content
Equibles

FNY Investment Advisers, LLC

Position in NAUT — Nautilus Biotechnology, Inc.

CIK 1742998 NEW YORK, NY
Back to NAUT Full portfolio

Position in NAUT

as of Jun 30, 2026 · filed Jul 8, 2026
Position Value
$26,180
-$28,140 QoQ
Shares Held
14,000
0.0% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NAUT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FNY Investment Advisers, LLC holds $6,470,178 across 59 Biotechnology names. NAUT ranks #29 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 7,605 $1,013,442
2 SGMT
Sagimet Biosciences Inc.
 109,250 $844,502
3
5,000 $663,650
4 JANX
Janux Therapeutics, Inc.
 30,850 $473,856
5 NKTR
Nektar Therapeutics
 5,500 $383,955
6 VERU
Veru Inc.
 105,081 $328,903
7 VKTX
Viking Therapeutics, Inc.
 8,170 $318,711
8 XENE
Xenon Pharmaceuticals Inc.
 4,000 $241,440

All Filings in NAUT

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $26,180 14,000
2026-03-31 $54,320 14,000
2025-12-31 $27,300 14,000
2025-09-30 $11,830 14,000
2025-06-30 $10,150 14,000
2025-03-31 $3 4,000
2024-12-31 $6 4,000
2022-06-30 $68,864 25,600
2022-03-31 $137,317 31,640
2021-12-31 $65,268 12,600
2021-06-30 $50,500 5,000